Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials - Kristensen, SL; Rørth, R; Jhund, PS (Lancet Diabetes Endocrinol, 2019)